Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: A randomized controlled trial
BMC Musculoskeletal Disorders Sep 02, 2017
Costas B, et al. – This study investigated the safety and efficacy of collagenase clostridium histolyticum (CCH) injection for the treatment of palmar Dupuytren disease nodules. Findings demonstrated significant improvement in palmar nodule size and hardness consequent to the delivery of a single CCH injection in the patients. Additionally, the safety of CCH was similar to that observed previously in patients with Dupuytren contracture.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries